This CAV1-mediated metformin sensitivity may extend beyond glycolysis since the drug also acts on complex I of the electron transport chain in cancer cells; hence it offers further clue for investigating CAV1 expression and response to anti-metabolic drugs. The gene discussed is CAV1; the disease is cancer.